{
    "code": "10000856",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000856",
    "time": "2023-09-28 22:14:57",
    "許可證字號": "衛署菌疫輸字第000856號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/03\/27",
    "發證\/登錄日期": "97\/03\/27",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA01000085606",
    "中文品名": "保蓓TM人類乳突病毒第16\/18型疫苗",
    "英文品名": "Cervarix TM Human Papillomavirus vaccine Type 16 and 18 (Recombinant, AS04 adjuvanted)",
    "適應症": "Cevarix為一適合9-25歲女性施打之疫苗，可用以預防致癌性人類乳突病毒(HPV)第16 型、第18型所引起之病變：\r\n1.子宮頸癌\r\n2.第2級與第3級子宮頸上皮內贅瘤(CIN)和子宮頸原位腺癌(AIS)\r\n3.第1級子宮頸上皮內贅瘤(CIN)\r\n4.第1級外陰上皮內贅瘤及第1級陰道上皮內贅瘤(VIN\/ValN)\r\nCervarix亦可用於26歲以上女性預防致癌性人類乳突病毒(HPV)第16型、第18型所引起之第1級子宮頸上皮內贅瘤(CIN)。",
    "劑型": "275懸浮注射劑",
    "包裝": "1支、10支、100支盒裝 單劑量0.5ml小瓶裝 單劑量0.5ml, 23G1 needle, 1支裝預充填型注射器附針頭 單劑量0.5ml, 23G1 needle and 25G1 needle, 2支裝預充填型注射器附針頭",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "疫苗;",
    "監視期限": "",
    "主成分略述": "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN",
    "限制項目": "02輸　入 1E須執行Phase IV Study",
    "申請商名稱": "荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "臺北市中正區忠孝西路一段66號23、24樓",
    "主製造廠": [
        {
            "製造廠名稱": "GlaxoSmithKline Biologicals S.A.",
            "製造廠廠址": "Parc de la Noire Epine, Avenue Fleming 20, Wavre, 1300, Belgium",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "調液、充填及包裝作業；含原料藥製造"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "委託包裝廠(貼標)"
        },
        {
            "製造廠名稱": "GLAXOSMITHKLINE BIOLOGICALS S.A.",
            "製造廠廠址": "89 RUE DE L&#39;INSTITUT 1330 RIXENSART-BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "BATCH RELEASE"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8012007000",
            "成分名稱": "HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "UG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8012007100",
            "成分名稱": "HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "UG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "0.5毫升懸浮液，盛裝於附有瓶塞之小瓶或附有針頭之10cm預充填型注射劑",
        "特殊劑型": "",
        "顏色": "混濁白色懸浮液",
        "特殊氣味": "無",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "040008560004-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000856&Seq=004&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Cervarix_仿單加蓋騎縫章_1091214-110-06-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000856&Seq=016&Type=9"
        },
        {
            "title": "Cervarix_IPI20_[CH]_依核定草本-109-02-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000856&Seq=014&Type=9"
        },
        {
            "title": "Cervarix carton_label-110-06-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000856&Seq=015&Type=8"
        },
        {
            "title": "02000856002-107-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000856&Seq=013&Type=8"
        }
    ]
}